Free Trial
NASDAQ:ENGNW

enGene (ENGNW) Stock Price, News & Analysis

$0.90 0.00 (0.00%)
(As of 12/20/2024 ET)

About enGene Stock (NASDAQ:ENGNW)

Key Stats

Today's Range
$0.90
$0.90
50-Day Range
$0.90
$2.10
52-Week Range
$0.42
$6.50
Volume
N/A
Average Volume
18,191 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Receive ENGNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.

ENGNW Stock News Headlines

Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
See More Headlines

ENGNW Stock Analysis - Frequently Asked Questions

enGene's stock was trading at $0.85 at the beginning of 2024. Since then, ENGNW shares have increased by 5.9% and is now trading at $0.90.
View the best growth stocks for 2024 here
.

Shares of ENGNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ENGNW
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ENGNW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners